Skip to main content
Advertisement
Advertisement

AGL

AGL logo

agilon health, inc.

83.06
USD
Sponsored
-2.64
-3.09%
Oct 08, 11:22 UTC -4
Open

AGL Earnings Reports

Positive Surprise Ratio

AGL beat 7 of 22 last estimates.

32%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.47B
/
-$1.20
Implied change from Q2 26 (Revenue/ EPS)
-1.55%
/
-215.38%
Implied change from Q3 25 (Revenue/ EPS)
+2.52%
/
-82.22%

agilon health, inc. earnings per share and revenue

On Aug 05, 2026, AGL reported earnings of 1.04 USD per share (EPS) for Q2 26, beating the estimate of -0.10 USD, resulting in a 1101.93% surprise. Revenue reached 1.49 billion, compared to an expected 1.46 billion, with a 2.23% difference. The market reacted with a -19.49% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -1.20 USD, with revenue projected to reach 1.47 billion USD, implying an decrease of -215.38% EPS, and decrease of -1.55% in Revenue from the last quarter.
FAQ
For Q2 2026, agilon health, inc. reported EPS of $1.04, beating estimates by 1101.93%, and revenue of $1.49B, 2.23% above expectations.
The stock price moved down -19.49%, changed from $107.85 before the earnings release to $86.83 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 11 analysts, agilon health, inc. is expected to report EPS of -$1.20 and revenue of $1.47B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement